UBD and metabolic dysfunction-associated steatotic liver disease: The transcript analysis in nonalcoholic fatty liver disease (NAFLD) patients showed that upregulation of proinflammatory cytokines IL-32 and FAT10 levels suggests a possible connection between FAT10 and inflammation responses in liver diseases (Dali-Youcef et al., 2019).